140 related articles for article (PubMed ID: 23749639)
21. In vitro activity of human translation initiation factor eIF4B is not affected by phosphomimetic amino acid substitutions S422D and S422E.
Shagam LI; Terenin IM; Andreev DE; Dunaevsky JE; Dmitriev SE
Biochimie; 2012 Dec; 94(12):2484-90. PubMed ID: 22750809
[TBL] [Abstract][Full Text] [Related]
22. Activation of Pim Kinases Is Sufficient to Promote Resistance to MET Small-Molecule Inhibitors.
An N; Xiong Y; LaRue AC; Kraft AS; Cen B
Cancer Res; 2015 Dec; 75(24):5318-28. PubMed ID: 26670562
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases.
Raught B; Peiretti F; Gingras AC; Livingstone M; Shahbazian D; Mayeur GL; Polakiewicz RD; Sonenberg N; Hershey JW
EMBO J; 2004 Apr; 23(8):1761-9. PubMed ID: 15071500
[TBL] [Abstract][Full Text] [Related]
24. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
25. The Pim-1 protein kinase is an important regulator of MET receptor tyrosine kinase levels and signaling.
Cen B; Xiong Y; Song JH; Mahajan S; DuPont R; McEachern K; DeAngelo DJ; Cortes JE; Minden MD; Ebens A; Mims A; LaRue AC; Kraft AS
Mol Cell Biol; 2014 Jul; 34(13):2517-32. PubMed ID: 24777602
[TBL] [Abstract][Full Text] [Related]
26. c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3.
Li X; Ma Q; Wang J; Liu X; Yang Y; Zhao H; Wang Y; Jin Y; Zeng J; Li J; Song L; Li X; Li P; Qian X; Cao C
Cell Death Differ; 2010 Aug; 17(8):1277-87. PubMed ID: 20150913
[TBL] [Abstract][Full Text] [Related]
27. Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway.
Shay KP; Wang Z; Xing PX; McKenzie IF; Magnuson NS
Mol Cancer Res; 2005 Mar; 3(3):170-81. PubMed ID: 15798097
[TBL] [Abstract][Full Text] [Related]
28. Identification of a phenanthrene derivative as a potent anticancer drug with Pim kinase inhibitory activity.
Wang YY; Taniguchi T; Baba T; Li YY; Ishibashi H; Mukaida N
Cancer Sci; 2012 Jan; 103(1):107-15. PubMed ID: 21981263
[TBL] [Abstract][Full Text] [Related]
29. The 44 kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs.
Xie Y; Xu K; Dai B; Guo Z; Jiang T; Chen H; Qiu Y
Oncogene; 2006 Jan; 25(1):70-8. PubMed ID: 16186805
[TBL] [Abstract][Full Text] [Related]
30. KSHV encoded LANA upregulates Pim-1 and is a substrate for its kinase activity.
Bajaj BG; Verma SC; Lan K; Cotter MA; Woodman ZL; Robertson ES
Virology; 2006 Jul; 351(1):18-28. PubMed ID: 16647097
[TBL] [Abstract][Full Text] [Related]
31. Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
Pogacic V; Bullock AN; Fedorov O; Filippakopoulos P; Gasser C; Biondi A; Meyer-Monard S; Knapp S; Schwaller J
Cancer Res; 2007 Jul; 67(14):6916-24. PubMed ID: 17638903
[TBL] [Abstract][Full Text] [Related]
32. Establishment and characterization of a novel imatinib-sensitive chronic myeloid leukemia cell line MYL, and an imatinib-resistant subline MYL-R showing overexpression of Lyn.
Ito T; Tanaka H; Kimura A
Eur J Haematol; 2007 May; 78(5):417-31. PubMed ID: 17432977
[TBL] [Abstract][Full Text] [Related]
33. FAK silencing inhibits leukemogenesis in BCR/ABL-transformed hematopoietic cells.
Le Y; Xu L; Lu J; Fang J; Nardi V; Chai L; Silberstein LE
Am J Hematol; 2009 May; 84(5):273-8. PubMed ID: 19358301
[TBL] [Abstract][Full Text] [Related]
34. Pim-2 Cooperates with Downstream Factor XIAP to Inhibit Apoptosis and Intensify Malignant Grade in Prostate Cancer.
Ren K; Gou X; Xiao M; He W; Kang J
Pathol Oncol Res; 2019 Jan; 25(1):341-348. PubMed ID: 29124675
[TBL] [Abstract][Full Text] [Related]
35. Bcr and Abl interaction: oncogenic activation of c-Abl by sequestering Bcr.
Ling X; Ma G; Sun T; Liu J; Arlinghaus RB
Cancer Res; 2003 Jan; 63(2):298-303. PubMed ID: 12543778
[TBL] [Abstract][Full Text] [Related]
36. Pim-1 kinase as activator of the cell cycle pathway in neuronal death induced by DNA damage.
Zhang Y; Parsanejad M; Huang E; Qu D; Aleyasin H; Rousseaux MW; Gonzalez YR; Cregan SP; Slack RS; Park DS
J Neurochem; 2010 Jan; 112(2):497-510. PubMed ID: 19895669
[TBL] [Abstract][Full Text] [Related]
37. Pim-1 kinase stimulates c-Myc-mediated death signaling upstream of caspase-3 (CPP32)-like protease activation.
Mochizuki T; Kitanaka C; Noguchi K; Sugiyama A; Kagaya S; Chi S; Asai A; Kuchino Y
Oncogene; 1997 Sep; 15(12):1471-80. PubMed ID: 9333023
[TBL] [Abstract][Full Text] [Related]
38. A pivotal role for Pim-1 kinase in esophageal squamous cell carcinoma involving cell apoptosis induced by reducing Akt phosphorylation.
Li S; Xi Y; Zhang H; Wang Y; Wang X; Liu H; Chen K
Oncol Rep; 2010 Oct; 24(4):997-1004. PubMed ID: 20811681
[TBL] [Abstract][Full Text] [Related]
39. Small GTPase RAB45-mediated p38 activation in apoptosis of chronic myeloid leukemia progenitor cells.
Nakamura S; Takemura T; Tan L; Nagata Y; Yokota D; Hirano I; Shigeno K; Shibata K; Fujie M; Fujisawa S; Ohnishi K
Carcinogenesis; 2011 Dec; 32(12):1758-72. PubMed ID: 21890458
[TBL] [Abstract][Full Text] [Related]
40. Pim-1 expression and monoclonal antibody targeting in human leukemia cell lines.
Li J; Hu XF; Loveland BE; Xing PX
Exp Hematol; 2009 Nov; 37(11):1284-94. PubMed ID: 19703513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]